
JNJ-47965567
CAS No. 1428327-31-4
JNJ-47965567( JNJ-479655 )
Catalog No. M23587 CAS No. 1428327-31-4
JNJ-47965567 is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel(with pKis of 7.9 and 8.7 for human and rat P2X7, respectively).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | In Stock |
![]() ![]() |
5MG | 72 | In Stock |
![]() ![]() |
10MG | 143 | In Stock |
![]() ![]() |
25MG | 286 | In Stock |
![]() ![]() |
50MG | 428 | In Stock |
![]() ![]() |
100MG | 610 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameJNJ-47965567
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-47965567 is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel(with pKis of 7.9 and 8.7 for human and rat P2X7, respectively).
-
DescriptionJNJ-47965567 is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel(with pKis of 7.9 and 8.7 for human and rat P2X7, respectively).
-
In Vitro——
-
In VivoAnimal Model:Male Sprague Dawley rats Dosage:30 mg/kg, 100 mg/kg Administration:Subcutaneous injection; 30 minutes prior to Bz-ATP infusion Result:Significantly attenuated IL-1β release at 100 mg/kg, with no effect at 30 mg/kg dose group.
-
SynonymsJNJ-479655
-
PathwayNeuroscience
-
TargetP2 Receptor
-
Recptorhuman P2X7|P2X7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1428327-31-4
-
Formula Weight488.64
-
Molecular FormulaC28H32N4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:200 mg/mL (409.30 mM; Need ultrasonic)
-
SMILESO=C(C1=CC=CN=C1SC2=CC=CC=C2)NCC3(N4CCN(C5=CC=CC=C5)CC4)CCOCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.[J]. British Journal of Pharmacology, 2013, 170(3):624-640.
molnova catalog



related products
-
JNJ-47965567
JNJ-47965567 is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel(with pKis of 7.9 and 8.7 for human and rat P2X7, respectively).
-
A-438079 hydrochlori...
A-438079 hydrochloride is a potent, and selective P2X7 receptor antagonist with pIC50 of 6.9.
-
A-317491
A-317491 is a non-nucleotide P2X3 ( Ki: 22 nM) and P2X2/3 receptor (Ki: 9 nM) antagonist, which inhibits calcium flux mediated by the receptors.